BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 223 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2019. The put-call ratio across all filers is 0.36 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $1,121,000 | +20.9% | 10,000 | 0.0% | 0.04% | +27.3% |
Q3 2020 | $927,000 | +18.8% | 10,000 | 0.0% | 0.03% | +6.5% |
Q2 2020 | $780,000 | +33.3% | 10,000 | 0.0% | 0.03% | +19.2% |
Q1 2020 | $585,000 | -27.0% | 10,000 | 0.0% | 0.03% | 0.0% |
Q4 2019 | $801,000 | +9.0% | 10,000 | 0.0% | 0.03% | 0.0% |
Q3 2019 | $735,000 | -80.6% | 10,000 | -78.9% | 0.03% | -81.8% |
Q1 2019 | $3,786,000 | +48.5% | 47,300 | 0.0% | 0.14% | +27.7% |
Q4 2018 | $2,550,000 | -28.2% | 47,300 | +4.0% | 0.11% | -21.7% |
Q3 2018 | $3,552,000 | +5.6% | 45,500 | -14.2% | 0.14% | -7.7% |
Q2 2018 | $3,364,000 | -4.1% | 53,000 | +38.6% | 0.16% | -10.9% |
Q1 2018 | $3,508,000 | – | 38,250 | – | 0.17% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP II, LLC | 878,875 | $70,354,000 | 45.87% |
CVI Holdings, LLC | 200,000 | $16,010,000 | 15.16% |
Foresite Capital Management III, LLC | 467,682 | $37,438,000 | 9.74% |
Casdin Capital, LLC | 848,648 | $67,934,000 | 7.46% |
BVF INC/IL | 564,965 | $45,225,000 | 5.06% |
Ghost Tree Capital, LLC | 240,000 | $19,212,000 | 5.02% |
DAFNA Capital Management LLC | 119,718 | $9,583,000 | 4.13% |
HHLR ADVISORS, LTD. | 1,498,516 | $119,956,000 | 3.34% |
Opaleye Management Inc. | 130,000 | $10,407,000 | 2.88% |
Perceptive Advisors | 1,271,054 | $101,748,000 | 2.87% |